Research Article| Volume 221, ISSUE 2, P527-535, April 2012

Download started.


Fate of individuals with ischemic amputations in the REACH Registry: Three-year cardiovascular and limb-related outcomes



      To evaluate systemic and limb ischemic event rates of PAD patients with prior leg amputation and determine predictors of adverse outcomes.


      The REduction of Atherothrombosis for Continued Health (REACH) Registry provided a prospective multinational cohort of 7996 outpatients with PAD enrolled from primary medical clinics in 44 countries in 2003–2004. 1160 patients (14.5%) had a prior leg amputation at any level. Systemic (myocardial infarction [MI], stroke, cardiovascular death) and limb (angioplasty, surgery, amputation) ischemic event rates were determined in a 3-year follow-up.


      PAD patients with leg amputations on entry had a 5-fold higher rate of a subsequent amputation (12.4% vs. 2.4%, P < .001), lower rate of peripheral angioplasty (8.3% vs. 10.7%, P = .005), and similar rates of surgical revascularization procedures compared with PAD patients without amputation. A nearly 2-fold increase in rates of cardiovascular death (14.5% vs. 7.7%, P < .001) and all-cause mortality (21.8% vs. 12.6%, P < .001) and an increase in the composite outcome of MI, stroke, cardiovascular death, or hospitalization (48.7% vs. 40.0%, P < .001) were noted. Recent (≤1 year) amputation was associated with higher rates of worsening PAD, subsequent lower extremity surgical revascularization procedures, re-amputation, non-fatal MI, and the composite outcome, including hospitalization. Adverse systemic and limb ischemic outcomes were similar regardless of amputation level.


      Individuals with a history of leg amputations have markedly elevated rates of systemic and limb-related outcomes. PAD patients with recent ischemic amputation have the highest risk of adverse events. A history of “minor” ischemic amputation may confer an identical systemic risk as “major” leg amputation.


      • We evaluated systemic and limb ischemic event rates of PAD patients with prior leg amputation from the REACH Registry.
      • PAD patients with prior amputation have markedly elevated rates of systemic and limb-related outcomes.
      • PAD patients with recent ischemic amputation have the highest risk of adverse events.
      • A history of minor ischemic amputation may confer an identical systemic risk as
      • major leg amputation.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hirsch A.T.
        • Haskal Z.J.
        • Hertzer N.R.
        • et al.
        ACC/AHA 2005 Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery. Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.
        J Am Coll Cardiol. 2006; 47: 1239-1312
        • Norgren L.
        • Hiatt W.R.
        • Dormandy J.A.
        • et al.
        • TASC II Working Group
        Inter-society consensus for the management of peripheral arterial disease (TASC II).
        J Vasc Surg. 2007; : S5-S67
        • Regenbogen S.E.
        • Gawande A.A.
        • Lipsitz S.R.
        • Greenberg C.C.
        • Jha A.K.
        Do differences in hospital and surgeon quality explain racial disparities in lower extremity vascular amputations?.
        Ann Surg. 2009; 250: 424-431
        • Most R.S.
        • Sinnock P.
        The epidemiology of lower extremity amputations in diabetic individuals.
        Diabetes Care. 1983; 6: 87-91
        • Feinglass J.
        • Pearce W.H.
        • Martin G.J.
        • et al.
        Postoperative and late survival outcomes after major amputation: findings from the Department of Veterans Affairs National Surgical Quality Improvement Program.
        Surgery. 2001; 130: 21-29
        • Uniwin N.
        Epidemiology of lower extremity amputation in centers in Europe. North America and East Asia. The global lower extremity amputation study group.
        Br J Surg. 2000; 87: 328-337
        • Aquino R.
        • Johnnides C.
        • Makaroun M.
        • et al.
        Natural history of claudication: long-term serial follow-up study of 1244 claudicants.
        J Vasc Surg. 2001; 36: 962-970
        • Engelhardt M.
        • Boos J.
        • Bruijnen H.
        • et al.
        Critical limb ischaemia: initial treatment and predictors of amputation-free survival.
        Eur J Vasc Endovasc Surg. 2012; 43 ([Epub 2011 Oct 15]): 55-61
        • Dormandy J.
        • Heeck L.
        • Vig S.
        Major amputations: clinical patterns and predictors.
        Semin Vasc Surg. 1999; 12: 154-161
        • Benoit E.
        • O’Donnell Jr., T.
        • Iafrati M.
        • et al.
        The role of amputation as an outcome measure in cellular therapy for critical limb ischemia: implications for clinical trial design.
        J Transl Med. 2011; 9: 165
        • Powell R.J.
        • Comerota A.J.
        • Berceli S.A.
        • et al.
        Interim analysis results from the RESTORE-CLI, a randomized, double-blind multicenter phase II trial comparing expanded autologous bone marrow-derived tissue repair cells and placebo in patients with critical limb ischemia.
        J Vasc Surg. 2011; 54: 1032-1041
        • Belch J.
        • Hiatt W.R.
        • Baumgartner I.
        • et al.
        Effect of fibroblast growth factor NV1FGF on amputation and death: a randomised placebo-controlled trial of gene therapy in critical limb ischaemia.
        Lancet. 2011; 377: 1929-1937
        • Kannel W.B.
        • Manning F.M.
        Natural history of angina pectoris in the Framingham study: prognosis and survival.
        Am J Cardiol. 1972; 29: 154-163
        • Lloyd-Jones D.
        • Adams R.
        • Carnethon M.
        • et al.
        Heart disease and stroke statistics—2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.
        Circulation. 2009; 119: e21-e181
        • Lewandowski C.A.
        • Rao C.P.
        • Silver B.
        Transient ischemic attack: definitions and clinical presentations.
        Ann Emerg Med. 2008; 52: S7-S16
        • Reiber G.E.
        • Pecoraro R.E.
        • Koepsell T.D.
        Risk factors for amputation in patients with diabetes mellitus. A case-control study.
        Ann Intern Med. 1992; 117: 97-105
        • Nash T.
        • Bellew J.W.
        • Cunningham M.
        • McCulloch J.
        Identifying cause for advancement to amputation in patients with diabetes: the role of medical care and patient compliance.
        Wounds. 2005; 17 (Available at: 32-36
        • Faglia E.
        • Clerici G.
        • Clerissi J.
        • et al.
        Long-term prognosis of diabetic patients with critical limb ischemia: a population-based cohort study.
        Diabetes Care. 2009; 32 ([erratum in: Diabetes Care 2009;32(7):1355]): 822-827
        • Varu V.N.
        • Hogg M.E.
        • Kibbe M.R.
        Critical limb ischemia.
        J Vasc Surg. 2010; 51: 230-241
        • Caro J.
        • Migliaccio-Walle K.
        • Ishak K.J.
        • Proskorovsky I.
        The morbidity and mortality following a diagnosis of peripheral arterial disease: long-term follow-up of a large database.
        BMC Cardiovasc Disord. 2005; 5: 14
        • Dick F.
        • Diehm N.
        • Galimanis A.
        • et al.
        Surgical or endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome.
        J Vasc Surg. 2007; 45: 751-761
        • Bhatt D.L.
        • Steg P.G.
        • Ohman E.M.
        • et al.
        • REACH Registry Investigators
        International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis.
        JAMA. 2006; 295: 180-189
        • Steg P.G.
        • Bhatt D.L.
        • Wilson P.W.
        • et al.
        • REACH Registry Investigators
        One-year cardiovascular event rates in outpatients with atherothrombosis.
        JAMA. 2007; 297: 1197-1206
        • Mayfield J.
        • Reiber G.E.
        • Maynard C.
        • et al.
        Survival following lower-limb amputation in a veteran population.
        J Rehabil Res Dev. 2001; 38: 341-345
        • Hirsch A.T.
        • Hartman L.
        • Town R.J.
        • Virnig B.A.
        National health care costs of peripheral arterial disease in the Medicare population.
        Vasc Med. 2008; 13: 209-215
        • Mahoney E.M.
        • Wang K.
        • Cohen D.J.
        • et al.
        • REACH Registry Investigators
        One-year costs in patients with a history of or at risk for atherothrombosis in the United States.
        Circ Cardiovasc Qual Outcomes. 2008; 1: 38-45
        • Peacock J.M.
        • Keo H.H.
        • Duval S.
        • et al.
        The incidence and health economic burden of ischemic amputation in Minnesota, 2005–2008.
        Prev Chronic Dis. 2011; 8: A141
        • Tan M.L.M.
        • Feng J.
        • Gordois A.
        • Wong E.S.D.
        Lower extremity amputation prevention in Singapore: economic analysis of results.
        Singapore Med J. 2011; 52: 662-668
        • De Frang R.D.
        • Taylor L.M.
        • Porter J.M.
        Basic data related to amputations.
        Ann Vasc Surg. 1991; 5: 202-207
        • Global Lower Extremity Amputation Study Group
        Epidemiology of lower extremity amputation in centres in Europe, North America and East Asia. The Global Lower Extremity Amputation Study Group.
        Br J Surg. 2000; 87: 328-337
        • Cacoub P.P.
        • Abola M.T.
        • Baumgartner I.
        • et al.
        • REACH Registry Investigators
        Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry.
        Atherosclerosis. 2009; 204: e86-e92
        • Tentolouris N.
        • Al-Sabbagh S.
        • Walker M.
        • Boulton A.J.
        • Jude E.B.
        Mortality in diabetic and nondiabetic patients after amputations performed from 1990 to 1995: a 5-year follow-up study.
        Diabetes Care. 2004; 27: 1598-1604
        • Cruz C.P.
        • Eidt J.F.
        • Capps C.
        • Kirtley L.
        • Moursi M.M.
        Major lower extremity amputations at a Veterans Affairs hospital.
        Am J Surg. 2003; 186: 449-454
        • Aulivola B.
        • Hile C.N.
        • Hamdan A.
        • et al.
        Major lower extremity amputation: outcome of a modern series.
        Arch Surg. 2004; 139: 395-399
        • Taylor S.
        • Kalbaugh C.A.
        • Blackhurst D.W.
        • et al.
        Preoperative clinical factors predict postoperative functional outcomes after major lower limb amputation: an analysis of 553 consecutive patients.
        J Vasc Surg. 2005; 42: 227-235
        • Trautner C.
        • Haastert B.
        • Spraul M.
        • Giani G.
        • Berger M.
        Unchanged incidence of lower-limb amputations in a German city, 1990–1998.
        Diabetes Care. 2001; 24: 855-859
        • Izumi Y.
        • Satterfield K.
        • Lee S.
        • Harkless L.B.
        • Lavery L.A.
        Mortality of first-time amputees in diabetics: a 10-year observation.
        Diabetes Res Clin Pract. 2009; 83: 126-131
        • Sandnes D.K.
        • Sobel M.
        • Flum D.R.
        Survival after lower extremity amputation.
        J Am Coll Surg. 2004; 199: 394-402
        • Faglia E.
        • Favales F.
        • Morabito A.
        New ulceration, new major amputation, and survival rates in Diabetic Subject Hospitalized for foot ulceration from 1990 to 1993: a 6.5-year follow-up.
        Diabetes Care. 2001; 24: 78-83
        • Calle-Pascual A.
        • Dura’n A.
        • Diaz A.
        • et al.
        Comparison of peripheral arterial construction in diabetic and non-diabetic patients: a prospective clinic-based study.
        Diab Res Clin Pract. 2001; 53: 129-136
        • Brown L.
        • Johnson J.
        • Majumdar S.
        • Tsuyuki R.
        • McAlister F.
        Evidence of suboptimal management of cardiovascular risk in patients with type 2 diabetes mellitus and symptomatic atherosclerosis.
        Canad Med Assoc J. 2004; 171: 1189-1192